Figure 6
Figure 6. BMPRIb receptor mediates BMP2 and BMP4 effects on LSC and myeloid progenitors. After qPCR analysis of BMPRIb expression, CP-CML samples were divided as low and high BMPRIb-expressing CML samples. CD34+ cells were then isolated from healthy donors (open bars) or both groups of CP-CML samples (closed bars) and incubated at 6 × 105/mL in serum-free medium for 7 days in the presence of BMP2 or BMP4 (50 ng/mL). (A) The SC content of the treated cells was analyzed using the LTC-IC cocultured assay; results represent the mean value ± SEM of the indicated number of samples. Results are presented as the total LTC-IC-derived week 5 colonies per 1 × 104 seeded cells. (B) The progenitor content of treated cells was analyzed using the CFC assay. Results are expressed as ratio of treated to untreated cells and represent the mean value ± SEM of the indicated number of samples. (C) BCR-ABL-transduced (closed bars) or empty vector-transduced (open bars) TF1 cells were continuously treated for 4 weeks by 50 ng/mL BMP2 or BMP4 and then assayed by CFC assay for their progenitor content. Results are expressed as the ratio of treated to untreated cells and represent the mean value ± SEM of 5 experiments. (D) Parental TF1 cells (TF1-wild-type) or TF1-BCR-ABL (TF1-BA) cells were transfected with a control empty (gray bars) or a BMPRIb-encoding (dark gray bars) vector. The effect on CFC output was analyzed using the CFC assay. Results are expressed as the total CFC colonies per 1 × 103 seeded cells and represent the mean value ± SEM of 7 or 3 experiments for TF1-wild-type and TF1-BCR-ABL, respectively. (E) The progenitor content of CD34+ cells isolated from healthy donors (open bars) or CP-CML (closed bars) samples. The cells were divided as low- and high-BMPRIb-expressing CML-samples and were treated for 7 days in serum-free medium by BMP2 or BMP4 (50 ng/mL) in the presence or absence of soluble BMPRIa or BMPRIb receptor (4 μg/mL). Results are expressed as ratio of treated to untreated cells and represent the mean value ± SEM of the indicated number of experiments. (F) The progenitor content of parental TF1 cells (TF1-wild-type; open bars) or TF1-BCR-ABL cells (closed bars) was analyzed by CFC assay after 48 hours of treatment by BMP2 or BMP4 (50 ng/mL), with or without soluble BMPRIb receptor (4 μg/mL). Results are expressed as the total CFC colonies per 1 × 103 seeded cells and represent the mean value ± SEM of 5 experiments. *P < .05 indicates differences between parental TF1 cells transduced with an empty vector and BCR-ABL-transduced TF1 cells.

BMPRIb receptor mediates BMP2 and BMP4 effects on LSC and myeloid progenitors. After qPCR analysis of BMPRIb expression, CP-CML samples were divided as low and high BMPRIb-expressing CML samples. CD34+ cells were then isolated from healthy donors (open bars) or both groups of CP-CML samples (closed bars) and incubated at 6 × 105/mL in serum-free medium for 7 days in the presence of BMP2 or BMP4 (50 ng/mL). (A) The SC content of the treated cells was analyzed using the LTC-IC cocultured assay; results represent the mean value ± SEM of the indicated number of samples. Results are presented as the total LTC-IC-derived week 5 colonies per 1 × 104 seeded cells. (B) The progenitor content of treated cells was analyzed using the CFC assay. Results are expressed as ratio of treated to untreated cells and represent the mean value ± SEM of the indicated number of samples. (C) BCR-ABL-transduced (closed bars) or empty vector-transduced (open bars) TF1 cells were continuously treated for 4 weeks by 50 ng/mL BMP2 or BMP4 and then assayed by CFC assay for their progenitor content. Results are expressed as the ratio of treated to untreated cells and represent the mean value ± SEM of 5 experiments. (D) Parental TF1 cells (TF1-wild-type) or TF1-BCR-ABL (TF1-BA) cells were transfected with a control empty (gray bars) or a BMPRIb-encoding (dark gray bars) vector. The effect on CFC output was analyzed using the CFC assay. Results are expressed as the total CFC colonies per 1 × 103 seeded cells and represent the mean value ± SEM of 7 or 3 experiments for TF1-wild-type and TF1-BCR-ABL, respectively. (E) The progenitor content of CD34+ cells isolated from healthy donors (open bars) or CP-CML (closed bars) samples. The cells were divided as low- and high-BMPRIb-expressing CML-samples and were treated for 7 days in serum-free medium by BMP2 or BMP4 (50 ng/mL) in the presence or absence of soluble BMPRIa or BMPRIb receptor (4 μg/mL). Results are expressed as ratio of treated to untreated cells and represent the mean value ± SEM of the indicated number of experiments. (F) The progenitor content of parental TF1 cells (TF1-wild-type; open bars) or TF1-BCR-ABL cells (closed bars) was analyzed by CFC assay after 48 hours of treatment by BMP2 or BMP4 (50 ng/mL), with or without soluble BMPRIb receptor (4 μg/mL). Results are expressed as the total CFC colonies per 1 × 103 seeded cells and represent the mean value ± SEM of 5 experiments. *P < .05 indicates differences between parental TF1 cells transduced with an empty vector and BCR-ABL-transduced TF1 cells.

Close Modal

or Create an Account

Close Modal
Close Modal